Doctor profile · Federal record
Dr. Rashad Ansari, MD
Rheumatology Physician (CMS: Rheumatology) · Vista, CA
- NPI 1063594372
- MIPS 82.9 / 100 · 2023
- 47 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
2023 W Vista Way, Ste. J
Vista, CA 920836030
(760) 724-6100
Credentials & registration
- NPI registered
- October 2006 — 20 yrs on file
- Profile last updated
- January 7, 2010
- Year of graduation
- 1979 — 47 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- California #G52073
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1063594372. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
11,763
Distinct HCPCS
10
Medicare allowed
$310,070
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 6,550 | 11 | $13 | |
J0897 |
Injection, denosumab, 1 mg | 3,004 | 39 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 822 | 309 | $139 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 712 | 79 | $1 | |
J7050 |
Infusion, normal saline solution, 250 cc | 181 | 30 | $1 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 155 | 29 | $74 | |
20610 |
Aspiration and/or injection of fluid from large joint | 102 | 66 | $78 | |
36415 |
Insertion of needle into vein for collection of blood sample | 77 | 68 | $8 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 39 | 16 | $150 | |
96372 |
Injection of drug or substance under skin or into muscle | 35 | 17 | $15 |
In context: peer comparison
Among 3 peers in Vista Rheumatology Physician, average services per provider: 3,857. This provider delivers 3.0× the peer median.Open Payments
Industry payments received
All-time total
$2,951
Transactions
126
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen INC. | 25 | $523.02 | |
| Abbvie INC. | 20 | $489.99 | |
| Janssen Biotech, INC. | 24 | $290.31 | |
| Ucb, INC. | 7 | $264.43 | |
| Lilly USA, LLC | 12 | $219.37 | |
| AstraZeneca Pharmaceuticals Lp | 9 | $187.98 | |
| Novartis Pharmaceuticals Corporation | 5 | $143.70 | |
| Pfizer INC. | 7 | $140.36 | |
| Janssen Scientific Affairs, LLC | 1 | $138.37 | |
| GlaxoSmithKline, LLC. | 5 | $136.95 | |
| Aurinia Pharma U.S., INC. | 3 | $106.40 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $86.86 | |
| Genentech USA, INC. | 3 | $63.99 | |
| BioCryst US Sales Co., LLC | 1 | $34.19 | |
| Actelion Pharmaceuticals US, INC. | 1 | $31.22 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,242
Patients
592
Total drug cost
$604,545
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 494 | 131 | $5,467 |
| Celecoxib | Generic | 300 | 82 | $17,524 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 225 | 45 | $5,320 |
| Meloxicam | Generic | 193 | 60 | $1,487 |
| Methotrexate (Methotrexate Sodium) | Brand | 149 | 38 | $6,933 |
| Hydroxychloroquine Sulfate | Generic | 146 | 34 | $12,185 |
| Gabapentin | Generic | 110 | 30 | $2,303 |
| Duloxetine Hcl | Generic | 107 | 30 | $3,949 |
| Tramadol Hcl | Generic | 99 | 28 | $756 |
| Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) | Brand | 89 | 12 | $4,258 |
Frequently asked questions
What is Dr. Rashad Ansari's medical specialty?
Dr. Rashad Ansari practices Rheumatology Physician in Vista, CA.
Where does Dr. Rashad Ansari practice?
Dr. Rashad Ansari practices at 2023 W Vista Way, Vista, CA 920836030. Office phone: 7607246100.
What is Dr. Rashad Ansari's NPI?
Dr. Rashad Ansari's National Provider Identifier (NPI) is 1063594372, issued by NPPES.
Does Dr. Rashad Ansari accept Medicare assignment?
Dr. Rashad Ansari does not accept Medicare assignment for all services. Patients may be billed amounts beyond Medicare-allowed charges.
What procedures does Dr. Rashad Ansari commonly perform?
Top Medicare-reported procedures in 2023: Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.